文献速递其他结缔组织病

系统性硬化症患者的免疫球蛋白G改变内皮细胞的分子特征

Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells.
PubMed 文献 · RMD Open · 2025-03-23

该研究将系统性硬化症(SSc)、系统性红斑狼疮(SLE)患者及健康对照(HC)的纯化IgG与内皮细胞(EC)共培养,用蛋白质组学和转录组学分析EC分子特征。结果显示SSc患者IgG可改变EC蛋白质组和转录组,且变化与抗核抗体(ANA)血清型密切相关;在SSc队列中未观察到功能性抗体(FA)与蛋白质组谱的关联。

要点

  • SSc患者纯化IgG可改变内皮细胞的蛋白质组和转录组特征。
  • EC蛋白质组谱与ANA血清型(ATA+、抗着丝点+、抗RNA聚合酶III+)相关。
  • 在两个SSc队列中,FA存在与蛋白质组谱之间未观察到关联。

核心结论

  • SSc患者纯化IgG可改变内皮细胞蛋白质组和转录组,所观察到的变化与ANA血清型密切相关。

研究设计与样本

  • 将SSc患者、SLE患者或健康对照的纯化IgG与内皮细胞共培养,用液相色谱-串联质谱(LC-MS/MS)和RNA测序分析EC组学谱,并用外部验证队列确认SSc患者IgG诱导的EC蛋白质组。

主要发现

  • 在推导队列中,基于蛋白质组学数据的主成分分析(PCA)显示三组受试者:第一组主要包含抗拓扑异构酶I阳性(ATA+)患者,第二组主要包含抗着丝点阳性患者,第三组包含抗RNA聚合酶III阳性患者、SLE和HC。
  • 在转录组学中,PCA将仅由ATA+患者组成的一组与ATA+患者和其他个体混合的另一组区分开。
  • 验证队列证实ATA+患者中存在两组不同的EC蛋白质组谱和临床严重程度。
  • 在两个SSc队列中,FA存在与蛋白质组谱之间未观察到关联。
  • 定量蛋白质组学测定了暴露于纯化IgG的EC中最具判别力的蛋白质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Antinuclear antibodies (ANA) are powerful biomarkers in systemic sclerosis (SSc). Functional antibodies (FA) might be implicated in vasculopathy, in which endothelial cells (EC) are key players. We aimed to explore the effect of purified IgG from patients with SSc on omics signatures of EC and examine the influence of ANA serotypes and FA. METHODS: EC were cultured in the presence of purified IgG from patients with SSc, patients with systemic lupus erythematosus (SLE) or healthy controls (HC). EC omics profiles were analysed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and RNA sequencing. EC proteome induced by IgG from patients with SSc was confirmed with an external validation cohort. RESULTS: In the derivation cohort, principal component analysis (PCA) using proteomics data showed three distinct groups of subjects: a first one including mostly anti-topoisomerase-I positive patients (ATA+), a second one including mostly anti-centromere positive patients and a third group comprising anti-RNA polymerase-III positive patients, SLE and HC. In transcriptomics, PCA distinguished one group composed of ATA+patients only from a second group mixing ATA+patients with other individuals. The validation cohort confirmed the existence of two groups of distinct EC proteome profiles and clinical severity in ATA+patients. In both SSc cohorts, no association between FA presence and proteomic profiles was observed. Quantitative proteomics measured the most discriminant proteins in EC exposed to purified IgG. CONCLUSION: Purified IgG from patients with SSc can modify EC proteome and transcriptome. The observed changes closely associate with ANA serotype.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Chepy A, Vivier S, Bray F, et al. Immunoglobulins G from Patients with Systemic Sclerosis Modify the Molecular Signatures of Endothelial Cells. RMD Open. 2025. PMID: 40122572. doi:10.1136/rmdopen-2024-004290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。